Cargando…

Replication Stress Response Modifies Sarcomeric Cardiomyopathy Remodeling

BACKGROUND: Sarcomere gene mutations lead to cardiomyocyte hypertrophy and pathological myocardial remodeling. However, there is considerable phenotypic heterogeneity at both the cellular and the organ level, suggesting modifiers regulate the effects of these mutations. We hypothesized that sarcomer...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pal, Soumojit, Nixon, Benjamin R., Glennon, Michael S., Shridhar, Puneeth, Satterfield, Sidney L., Su, Yan Ru, Becker, Jason R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8475701/ https://www.ncbi.nlm.nih.gov/pubmed/34323119 http://dx.doi.org/10.1161/JAHA.121.021768

Ejemplares similares

MDM2 Regulation of HIF Signaling Causes Microvascular Dysfunction in Hypertrophic Cardiomyopathy
por: Shridhar, Puneeth, et al.
Publicado: (2023)

Sarcomere mutation negative hypertrophic cardiomyopathy is associated with ageing and obesity
por: de Feria, Alejandro E, et al.
Publicado: (2021)

Muscle-specific stress fibers give rise to sarcomeres in cardiomyocytes
por: Fenix, Aidan M, et al.
Publicado: (2018)

Genetic advances in sarcomeric cardiomyopathies: state of the art
por: Ho, Carolyn Y., et al.
Publicado: (2015)

Penetrance of Hypertrophic Cardiomyopathy in Sarcomere Protein Mutation Carriers
por: Lorenzini, Massimiliano, et al.
Publicado: (2020)

Prediction and visualization data for the interpretation of sarcomeric and non-sarcomeric DNA variants found in patients with hypertrophic cardiomyopathy
por: Bottillo, Irene, et al.
Publicado: (2016)

Sarcomeric perturbations of myosin motors lead to dilated cardiomyopathy in genetically modified MYL2 mice
por: Yuan, Chen-Ching, et al.
Publicado: (2018)

A Contraction Stress Model of Hypertrophic Cardiomyopathy due to Sarcomere Mutations
por: Cohn, Rachel, et al.
Publicado: (2018)

Direct Sarcomere Modulators Are Promising New Treatments for Cardiomyopathies
por: Tsukamoto, Osamu
Publicado: (2019)

Pathogenic Mechanisms of Hypertrophic Cardiomyopathy beyond Sarcomere Dysfunction
por: Chou, Chun, et al.
Publicado: (2021)

Childhood Hypertrophic Cardiomyopathy: A Disease of the Cardiac Sarcomere
por: Norrish, Gabrielle, et al.
Publicado: (2021)

Comparative analysis of right ventricular strain in Fabry cardiomyopathy and sarcomeric hypertrophic cardiomyopathy
por: Meucci, Maria Chiara, et al.
Publicado: (2022)

The Definition of Sarcomeric and Non-Sarcomeric Gene Mutations in Hypertrophic Cardiomyopathy Patients: A Multicenter Diagnostic Study Across Türkiye
por: Oktay, Veysel, et al.
Publicado: (2023)

Contribution of Post-translational Phosphorylation to Sarcomere-Linked Cardiomyopathy Phenotypes
por: Westfall, Margaret V.
Publicado: (2016)

Multimodality Imaging in Sarcomeric Hypertrophic Cardiomyopathy: Get It Right…on Time
por: Galluzzo, Alessandro, et al.
Publicado: (2023)

Microstructural and Microvascular Phenotype of Sarcomere Mutation Carriers and Overt Hypertrophic Cardiomyopathy
por: Joy, George, et al.
Publicado: (2023)

Sex-Related Differences in Protein Expression in Sarcomere Mutation-Positive Hypertrophic Cardiomyopathy
por: Schuldt, Maike, et al.
Publicado: (2021)

Sarcomeric gene variants among Indians with hypertrophic cardiomyopathy: A scoping review
por: Koshy, Linda, et al.
Publicado: (2023)

Temporal Trend of Age at Diagnosis in Hypertrophic Cardiomyopathy: An Analysis of the International Sarcomeric Human Cardiomyopathy Registry
por: Canepa, Marco, et al.
Publicado: (2020)

Disruption of embryonic ROCK signaling reproduces the sarcomeric phenotype of hypertrophic cardiomyopathy
por: Bailey, Kate E., et al.
Publicado: (2019)

Disruption of embryonic ROCK signaling reproduces the sarcomeric phenotype of hypertrophic cardiomyopathy
por: Bailey, Kate E., et al.
Publicado: (2020)

Hypertrophic Cardiomyopathy in Children: Pathophysiology, Diagnosis, and Treatment of Non-sarcomeric Causes
por: Monda, Emanuele, et al.
Publicado: (2021)

Preclinical alterations in cardiac energetics amongst sarcomere mutation carriers in hypertrophic cardiomyopathy
por: Lloyd, Rachael, et al.
Publicado: (2015)

Contribution of sarcomere gene mutations to left atrial function in patients with hypertrophic cardiomyopathy
por: Chung, Hyemoon, et al.
Publicado: (2021)

Effect of sarcomere and mitochondria-related mutations on myocardial fibrosis in patients with hypertrophic cardiomyopathy
por: Chung, Hyemoon, et al.
Publicado: (2021)

Analysis of the Serum Peptidomics Profile for Cats With Sarcomeric Gene Mutation and Hypertrophic Cardiomyopathy
por: Sukumolanan, Pratch, et al.
Publicado: (2021)

Pathogenesis of Cardiomyopathy Caused by Variants in ALPK3, an Essential Pseudokinase in the Cardiomyocyte Nucleus and Sarcomere
por: Agarwal, Radhika, et al.
Publicado: (2022)

Genotype and Lifetime Burden of Disease in Hypertrophic Cardiomyopathy: Insights From the Sarcomeric Human Cardiomyopathy Registry (SHaRe)
por: Ho, Carolyn Y., et al.
Publicado: (2018)

Titin stiffness modifies the force-generating region of muscle sarcomeres
por: Li, Yong, et al.
Publicado: (2016)

Distorting the sarcomere
por: Campbell, Kenneth S.
Publicado: (2010)

Modelling sarcomeric cardiomyopathies in the dish: from human heart samples to iPSC cardiomyocytes
por: Eschenhagen, Thomas, et al.
Publicado: (2015)

Connecting Sarcomere Protein Mutations to Pathogenesis in Cardiomyopathies: The Development of “Disease in a Dish” Models
por: Zaunbrecher, Rebecca, et al.
Publicado: (2016)

Defining the genetic architecture of hypertrophic cardiomyopathy: re-evaluating the role of non-sarcomeric genes
por: Walsh, Roddy, et al.
Publicado: (2017)

Clinical implications of sarcomere and nonsarcomere gene variants in patients with left ventricular noncompaction cardiomyopathy
por: Li, Shijie, et al.
Publicado: (2019)

Regression of Left Ventricular Hypertrophy in a Case of Sarcomeric Hypertrophic Cardiomyopathy: An Unexpected Outcome
por: Cabrera Borrego, Eva, et al.
Publicado: (2020)

Myocardial Deformation Analysis in MYBPC3 and MYH7 Related Sarcomeric Hypertrophic Cardiomyopathy—The Graz Hypertrophic Cardiomyopathy Registry
por: Höller, Viktoria, et al.
Publicado: (2021)

Proteomic and phosphoproteomic analyses of myectomy tissue reveals difference between sarcomeric and genotype-negative hypertrophic cardiomyopathy
por: Garmany, Ramin, et al.
Publicado: (2023)

Signalling in sarcomeres in development and disease
por: van Eldik, W., et al.
Publicado: (2013)

Proteomic and Functional Studies Reveal Detyrosinated Tubulin as Treatment Target in Sarcomere Mutation-Induced Hypertrophic Cardiomyopathy
por: Schuldt, Maike, et al.
Publicado: (2021)

In vivo Sarcomere Lengths and Sarcomere Elongations Are Not Uniform across an Intact Muscle
por: Moo, Eng Kuan, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_0iqoisdvlmrsrvf0vu87gep99j